Capital Flow Monitor · Sponsors · CIK 1505556
ARC Medical Inc.
#8 - 3071 No. 5 Road, RICHMOND, A1, V6X 2T4 · (604) 222-9577
Biotechnology · Corporation· inc. BRITISH COLUMBIA, CANADA true
Fit score
—
Offering
—
Sold
$1.5M
% sold
—
Investors
10
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-10-09 | D/A | 506(b) | $167K | $167K | 100.0% | 3 | EDGAR ↗ |
| 2026-08-10 | D | 506(b) | $118K | $118K | 100.0% | 2 | EDGAR ↗ |
| 2025-11-10 | D/A ·current | 506(b) | — | $1.5M | — | 10 | EDGAR ↗ |
| 2025-11-06 | D/A | 506(b) | $1.4M | $1.4M | 100.0% | 10 | EDGAR ↗ |
| 2025-10-15 | D/A | 506(b) | $1.0M | $1.0M | 100.0% | 10 | EDGAR ↗ |
| 2025-08-07 | D/A | 506(b) | $901K | $901K | 100.0% | 9 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Christopher Springate — Director / Executive Officer, Richmond, A1
- Bruce Hay — Director, Richmond, A1
-
Deng Mao — Director, Richmond, A1
2 other raises
- TECLens, Inc. $5.2M of $10.2M · 51.1%
- CSA Medical, Inc. $2.9M of $11.2M · 25.9%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.